第78回 日本循環器学会学術集会

本DVDの収録演題は以下を予定しております。

開会式
永井 良三 (自治医科大学／東京大学)
美甘レクチャー
Chairperson：
Yoshio Yazaki (International University of Health and Welfare, Tokyo)
ML. Molecular Control of Heart Development, Disease and Regeneration
Eric N. Olson (University of Texas, Southwestern Medical Center, USA)
真下記念講演
座長：
篠山 重威 (宇治病院)
MML. Signaling and Gene Expression for Cytokine Activity in Inflammation and Immunity: Contributions to Medical Science
谷口 維紹 (東京大学生産技術研究所 炎症・免疫制御学社会連携研究部門)
会長講演
座長：
矢﨑 義雄 (国際医療福祉大学)
CCL. Cardiology in the Information Era: From Bench to Community
永井 良三 (自治医科大学／東京大学)
特別講演
特別講演 1
Chairperson：
Shinichi Takamoto (Mitsui Memorial Hospital, Tokyo)
SL01. New Insights Regarding the Pathogenesis and Modification of Marfan Syndrome and Related Disorders
Harry Dietz (Johns Hopkins University School of Medicine, USA)
特別講演 2
Chairperson：
Koichi Node (Department of Cardiovascular Medicine, Saga University, Saga)
SL02. Adipokine Involvement in Cardiovascular Disease
Kenneth Walsh (Boston University School of Medicine, USA)
特別講演 3
Chairperson：
Makiko Ueda (Department of Pathology, Osaka City University Graduate School of Medicine, Osaka)
SL03. Update on the Pathophysiology of Acute Myocardial Infarction
Peter Libby (Brigham and Women’s Hospital and Harvard Medical School, USA)
特別講演 4
Chairperson：
Issei Komuro (Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo)
SL04. Genetic Causes of Human Heart Disease
Christine E. Seidman (Brigham & Women’s Hospital and Harvard Medical School, USA)
特別講演 5
Chairperson：
Hiroyuki Tsutsui (Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo)
SL05. microRNAs in Cardiovascular Diseases and Aging: From Mechanisms to Therapeutic Targets
Stefanie Dimmeler (Institute of Cardiovascular Regeneration, Germany)
特別講演 6
Chairperson：
Hiroaki Shimokawa (Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai)
SL06. Hypoxia and Vascular Physiology
Randall S. Johnson (Department of Physiology, University of Cambridge, UK)
特別講演 7
Chairperson：
Toyoaki Murohara (Nagoya University, Nagoya)
SL07. Differential Effects of Preload and Afterload on Myocardial Gene Expression and Function
Gerd Hasenfuss (University Medical Center Goettingen, Georg-August University Goettingen, Germany)
特別講演 10
Chairperson：
Kazutaka Aonuma (Cardiovascular Division, University of Tsukuba, Tsukuba)
SL10. Clinical Research and the Development of Medical Therapeutics
Elliott Antman (Brigham and Women’s Hospital, USA)
特別講演 11
Chairperson：
Hiroyuki Daida (Department of Cardiology, Juntendo University, Tokyo)
SL11. Mechanisms for Diabetic Cardiomyopathy―Focus on Hyperinsulinemia
E. Dale Abel (University of Iowa, Carver College of Medicine and Fraternal Order of Eagles Diabetes Research Center, USA)
特別講演 14
Chairperson：
Masafumi Kitakaze (National Cerebral and Cardiovascular Center, Suita)
SL14. Heart Failure with pEF
Michel Komajda (IHU ICAN, Department of Cardiology, University Pierre et Marie Curie, France)
会長特別企画
会長特別企画 1
座長：
永井 良三 (自治医科大学／東京大学)
尾身 茂 (独立行政法人 地域医療機能推進機構理事長 名誉世界保健機関（WHO）西太平洋地域事務局長 自治医科大学客員教授)
SS1-1. Overview
永井 良三 (自治医科大学／東京大学)
SS1-2. How to Overcome Challenges the Health System is Faced with?
尾身 茂 (自治医科大学年金／健康保険福祉施設整理機構)
SS1-3. Health Care Policy in a Hyper-aged Society
島崎 謙治 (政策研究大学院大学 政策研究科)
SS1-4. The New Direction of Primary Care in Japan
丸山 泉 (日本プライマリ・ケア連合学会)
SS1-5. How can National Healthcare Policy Focus on Community
堀 真奈美 (東海大学 人間環境学科)
会長特別企画 3
座長：
小川 久雄 (熊本大学／国立循環器病研究センター 循環器内科学)
髙本 眞一 (三井記念病院)
SS3-1. Learning the JCS Nationwide Survey of Cardiovascular Practice during 2004-2010: Topographic Disparity among 47 Prefectures
友池 仁暢 (榊原記念病院)
SS3-2. Rapid Dissemination of Coronary CT Angiography among Teaching Hospitals in Japan between 2007 and 2010
横山 広行 (国立循環器病研究センター 心臓血管内科)
SS3-3. Tag-Team Action of the Japanese Registry of All Cardiac and Vascular Diseases between JCS and National Cerebral and Cardiovascular Center
安田 聡 (国立循環器病研究センター 心臓血管内科)
SS3-4. Nationwide Cardiovascular Surgery Database: Japan Cardiovascular Surgery Database (JCVSD)
本村 昇 (東京大学 心臓外科)
SS3-5. For Whom does the Database Benefit: Implication from the National PCI Registries
香坂 俊 (慶應義塾大学 循環器内科／第一三共 心血管炎症学寄附講座)
会長特別企画 4
座長：
興梠 貴英 (自治医科大学 企画経営部・医療情報部)
植田 真一郎 (琉球大学 臨床薬理学講座)
SS4-1. Regulations on Investigator-Initiated Clinical Research
景山 茂 (東京慈恵会医科大学 総合医科学研究センター 薬物治療学研究室)
※こちらの演題は収録しておりません。
SS4-2. What do We Need to Activate Clinical Trials?
平山 佳伸 (立命館大学 薬学部)
SS4-3. Better Ways to Conduct Clinical Trials in Japan: From the Viewpoint of a Physician Statistician
興梠 貴英 (自治医科大学 企画経営部・医療情報部)
SS4-4. Proper Training Program for Physicians and Sharable Infrastructure is Required for Sensible, Physicianinitiated Clinical Research
植田 真一郎 (琉球大学 臨床薬理学講座)
SS4-5. TBA
Christina Reith (Nuffield Department of Population Health University of Oxford)
会長特別企画 6
座長：
油谷 浩幸 (東京大学 先端科学技術研究センター)
宮野 悟 (東京大学医科学研究所 ヒトゲノム解析センター)
SS6-1. Epigenomic Switch in Cardiomyocyte Differentiation
油谷 浩幸 (東京大学 先端科学技術研究センター)
SS6-2. Exploring Rare Genetic Variants in Association with Aortic Aneurysm and/or Dissection
松本 直通 (横浜市立大学 遺伝学)
SS6-3. Identification of Novel Susceptibility Loci for Myocardial Infarction Using Large-scale Genomic Analysis
森田 啓行 (東京大学 健康医科学創造講座)
SS6-4. Searching Target Genes by Gene Network Analysis with Supercomputer
宮野 悟 (東京大学医科学研究所 ヒトゲノム解析センター)
会長特別企画 7
座長：
永井 良三 (自治医科大学／東京大学)
SS7. 利益相反を考える
児玉 安司 (新星総合法律事務所)
プレナリーセッション
Plenary Session 1 (CAD)
Chairperson：
Atsushi Hirayama (Division of Cardiology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo)
Nico H.J. Pijls (Catharina Hospital, the Netherlands)
PL01-ART. State-of-the-Art： Coronary Revascularization Based on Evidence Based Medicine. Comparing PCI and CABG. Reality and Ideal
Nico H.J. Pijls (Catharina Hospital, the Netherlands)
PL01-1. Unique Characteristics of PCI in Japan and Its Implication in Selecting Revascularization Strategies
Shun Kohsaka (Department of Cardiology, Keio University School of Medicine, Tokyo)
PL01-2. The Predictor of Long-term Mortality in Patients with Unprotected Left Main Disease
Kensuke Takagi (Department of Cardiology, New Tokyo Hospital, Matsudo)
PL01-3. Prognostic Impacts of Revascularization Strategy and Residual Coronary Stenosis in Patients with Ischemic Heart Failure
Jun Takahashi (Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai)
PL01-4. Heart Team Approach as a Solution of Insufficient EBM
Yoshitaka Okamura (Department of Thoracic and Cardiovascular Surgery, Wakayama Medical University, Wakayama)
PL01-5. Impact of Heart Team on the Strategy for Coronary Revascularization in Our Hospital
Tadateru Takayama (Division of Cardiology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo)
Plenary Session 2 (HF)
Chairperson：
Mitsuaki Isobe (Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo)
Stefan D. Anker (Applied Cachexia Research, Department of Cardiology, Charité, Campus Virchow-Klinikum, Germany)
PL02-ART. State-of-the-Art：Progress in Heart Failure Treatment―Update on Acute & Chronic HF
Stefan D. Anker (Applied Cachexia Research, Department of Cardiology, Charite, Campus Virchow-Klinikum, Germany)
PL02-1. Next Generation Natriuretic Peptides for Heart Failure: Individualized Therapeutics
Tomoko Ichiki (Division of Cardiovascular Diseases, Mayo Clinic, USA)
PL02-2. The Long-term Prognostic Impact and Safety of Mesenchymal Stem Cells Transplantation in Patients with Non-ischemic/Ischemic Cardiomyopathy
Takeshi Yagyu (Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka)
PL02-3. Clinical Outcome of Left Ventricular Assist Device (LVAD) in Patients with Advanced Heart Failure in NonTransplant Institution
Taro Sasaoka (Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo)
PL02-4. Important Issues to be Challenged for Improvement of Left Ventricular Assist Device Therapy
Yasushi Sakata (Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita)
PL02-5. Progress in Surgical Treatment of End-stage Heart Failure
Minoru Ono (Department of Cardiac Surgery, The University of Tokyo, Tokyo)
Plenary Session 3 (HF)
Chairperson：
Keiichi Fukuda (Department of Cardiology, Keio University School of Medicine, Tokyo)
Issei Komuro (Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo)
PL03-1. Modeling Heart Regeneration in Zebrafish
Kenneth D. Poss (Duke University Medical Center, USA)
PL03-2. Transcriptional Regulation of Cardiomyocyte Cell Cycle
Hesham A. Sadek (UT Southwestern Medical Center, USA)
PL03-3. Reprogramming into Cardiomyocytes by Defined Factors
Masaki Ieda (Department of Clinical and Molecular Cardiovascular Research, Department of Cardiology, Keio University School of Medicine, Tokyo)
PL03-4. Cell-sheet-based Bioengineered Human Cardiac Tissue Using iPS Cells for Transplantation and Tissue Models
Katsuhisa Matsuura (Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University, Tokyo)
※こちらの演題は収録しておりません。
プレナリーセッション 4(O)
座長：
山崎 力 (東京大学 臨床研究支援センター)
木村 一雄 (横浜市立大学市民総合医療センター 心臓血管センター)
PL04-1. Reliable Evidence should Stand on Harmonization of Well-Designed Observational Studies, Clinical Trials and Basic Science Research
上島 弘嗣 (滋賀医科大学 公衆衛生学)
PL04-2. Strategies to Strengthen Investigator-Driven Cardiovascular Clinical Trials in Japan
渡邉 裕司 (浜松医科大学 臨床薬理学)
PL04-3. A Multidisciplinary Approach to Insure Scientific Integrity in Clinical Research for Heart Disease: jCUTE Proposal
坂東 興 (東京慈恵会医科大学 心臓外科)
PL04-4. The Immediate and Keen Action is Needed for the Investigator-initiated Clinical Trial of Cardiovascular Fields in Japan
北風 政史 (国立循環器病研究センター 臨床研究部)
PL04-5. Tactics to Conduct Clinical Trials Leading the Better Medical Guidelines for the Management of Cardiovascular Diseases
佐藤 直樹 (日本医科大学武蔵小杉病院 循環器内科)
プレナリーセッション 8(O)
座長：
砂川 賢二 (九州大学 循環器内科学)
澤 芳樹 (大阪大学 心臓血管外科学)
PL08-1. Academic Drug Development for Treatment of Acute Myocardial Infarction Using Nano-sized Liposomes
南野 哲男 (大阪大学 循環器内科学)
PL08-2. Clinical Application of Novel Angiogenic Peptide for Severe Ischemic Ulcer; from Discovery to Drug Development from Academia
中神 啓徳 (大阪大学 健康発達医学講座)
PL08-3. Translational Perspectives of Adrenomedullin; A Novel Therapeutic Options for Cardiovascular Diseases
浅海 泰栄 (国立循環器病研究センター)
PL08-4. Myocardial Regenerative Therapy Using Myoblast Cell Sheet in Patients with End-stage Heart Failure―From Bench to Clinical Trial―
吉川 泰司 (大阪大学 心臓血管外科)
PL08-5. A Device-Based Treatment of Heart Failure by Stimulating Vagal Nervous System
杉町 勝 (国立循環器病研究センター研究所 循環動態制御部)
PL08-6. Artificial Baroreflex System Prevents Postural Hypotension in Patients with Cervical Spinal Cord Injury
吉田 昌義 (済生会熊本病院 心臓血管センター 循環器内科)
シンポジウム
シンポジウム 1(CAD)
座長：
下川 宏明 (東北大学 循環器内科学)
山岸 正和 (金沢大学 臓器機能制御学・循環器内科)
SY01-1. Concepts and Limitations of Coronary Flow Reserve to Evaluate Myocardial Ischemia
盛 英三 (東海大学 生理科学)
SY01-2. Trend Pathological Aspects of Myocardial Infarction in the Reperfusion Era
松本 学 (国立循環器病研究センター 臨床検査部 病理)
SY01-3. Important Role of the Adventitia in the Pathogenesis of Coronary Hyperconstricting Responses after Drug-Eluting Stent Implantation in Pigs in Vivo
西宮 健介 (東北大学 循環器内科)
※こちらの演題は収録しておりません。
SY01-4. Instantaneous Wave Free Ratio (iFR) as the New Adenosine Free Resting Parameter to Detect Ischemia Causing Stenosis
松尾 仁司 (岐阜ハートセンター 循環器内科)
SY01-5. Long-term Outcome after Deferral of Revascularization in Patients with Intermediate Coronary Stenosis and Gray-Zone Fractional Flow Reserve
塩野 泰紹 (和歌山県立医科大学 循環器内科学)
SY01-6. Impact of Fractional Flow Reserve after 2nd-generation Drug-eluting Stent Deployment on Clinical Outcome
寺井 英伸 (金沢循環器病院 循環器科)
Symposium 2(CAD)
Chairperson：
Masahiko Kurabayashi (Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Maebashi)
Renu Virmani (CVPath Institute, Inc., USA)
SY02-KEY. Keynote Lecture： Pathophysiology of Atherosclerosis Plaque Progression
Renu Virmani (CVPath Institute, Inc., USA)
※こちらの演題は収録しておりません。
SY02-1. Risk Factors for Development of Systemic Atherosclerosis in Patients with Peripheral Arterial Disease
Hisao Kumakura (Vascular Center, Internal Medicine, Kitakanto Cardiovascular Hospital, Gunma)
※こちらの演題は収録しておりません。
SY02-2. Identification of Multiple Biomarkers That Predict the Extent of Plaque Burden in Coronary Culprit Lesions
Yuxin Li (Department of Advanced Cardiovascular Imaging, Nihon University School of Medicine, Tokyo)
SY02-3. Regulation of Arterial Stiffness by Klotho: Decreased Serum Klotho in CKD and Altered Osteogenesis-gene Expression in Klotho Mutant Mice SMCs
Kazufumi Nakamura (Department of Cardiovascular Medicine, Okayama University, Okayama)
SY02-4. Glucagon-like Peptide-1 in Pathogenesis of Atherosclerosis and Coronary Artery Disease
Koichi Sugamura (Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University, Kumamoto)
Symposium 4(A)
Chairperson：
Kazutaka Aonuma (Cardiovascular Division, University of Tsukuba, Tsukuba)
Paolo Della Bella (San Raffaele Hospital, Italy)
SY04-KEY. Keynote Lecture： Catheter Ablation of VT and Electrical Storm: Impact on Patient Survival
Paolo Della Bella (San Raffaele Hospital, Italy)
SY04-1. Catheter Ablation for Ventricular Tachycardias in Patients with Structural Heart Disease: Characteristics between the Patients with and without Myocardial Scar
Yukio Sekiguchi (Cardiovascular Division, Faculty of Medicine, University of Tsukuba, Tsukuba)
※こちらの演題は収録しておりません。
SY04-3. Current Outcomes of Hybrid Ablation Procedures for Electrical Storm of Ventricular Tachycardia
Michifumi Tokuda (Department of Cardiology, The Jikei University School of Medicine, Tokyo)
SY04-4. Surgery for Non-ischemic Ventricular Tachycardia
Takashi Nitta (Department of Cardiovascular Surgery, Nippon Medical School, Tokyo)
SY04-5. Ventricular Tachyarrhythmia in Cardiac Sarcoidosis: Clinical and Electrophysiological Characteristics
Kengo Kusano (Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita)
SY04-6. Scar Size and Characteristics Assessed by 2D and 3D Gadolinium enhanced MRI Imaging Predict the Inducibility and Origin of Ventricular Arrhythmias
Yasuo Okumura (Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo)
シンポジウム 5(HF)
座長：
筒井 裕之 (北海道大学 循環病態内科学)
小野 稔 (東京大学 心臓外科)
SY05-1. Sufficient Beta Blocker Therapy is a Key Factor before Determining the Indication for Left Ventricular Assist Device (LVAD) Implantation
絹川 弘一郎 (東京大学 重症心不全治療開発講座)
SY05-2. Necessity of a Comprehensive Treatment Approach for Heart Failure Patients
志賀 剛 (東京女子医科大学 循環器内科学)
SY05-3. The Most Promising Cell Therapy for the Failing Heart and Its Application in Japan
細田 徹 (東海大学 創造科学技術研究機構・医学部門)
SY05-4. Advances in Ventricular Assist Device Therapy: A Collaborative Approach between Cardiologists and Cardiac Surgeons
瀬口 理 (国立循環器病研究センター 移植部)
SY05-5. Importance of Heart Team Approach for Class IIIb／IV Heart Failure: Ventricular Assist Device or Conventional Surgery
戸田 宏一 (大阪大学 心臓血管外科)
Symposium 6(HF)
Chairperson：
Yoshihiko Saito (The First Department of Internal Medicine, Nara Medical University, Kashihara)
Gerd Hasenfuss (University Medical Center Goettingen, Georg-August University Goettingen, Germany)
SY06-KEY. Keynote Lecture：Excitation-Contraction Coupling in Human Heart Hypertrophy and Failure
Gerd Hasenfuss (University Medical Center Goettingen, Georg-August University Goettingen, Germany)
SY06-1. Dissociation of Calmodulin from RyR2 Plays a Key Role in Diastolic Ca2＋ Leak from Sarcoplasmic Reticulum in Pressure-overload Heart Failure
Takeshi Yamamoto (Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube)
SY06-2. Dynamic Crosstalk at the Cell and Organ Levels in the Cardiac Adaptive Response and Heart Failure
Ichiro Manabe (Department of Cardiovascular Medicine, The University of Tokyo Graduate School of Medicine, Tokyo)
※こちらの演題は収録しておりません。
SY06-3. Regulatory Mechanisms of Post-infarction Inflammation and Left Ventricular Remodeling
Toshihisa Anzai (Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka)
SY06-4. Perturbation of the Titin/MURF1 Signaling Complex is Associated with Cardiac Hypertrophy in a Fish Model and in Human Patients
Shinji Makino (Department of Cardiology, Keio University School of Medicine, Tokyo)
※こちらの演題は収録しておりません。
SY06-5. Molecular Mechanism of Gender Difference in Heart Failure Caused by Lamin A/C Mutations
Akinori Kimura (Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Tokyo)
シンポジウム 11(O)
座長：
楠岡 英雄 (国立病院機構大阪医療センター)
横山 広行 (国立循環器病研究センター)
SY11-1. The Japanese Registry Of All cardiac and vascular Diseases (JROAD) on the Road to the Future National Registry
安田 聡 (国立循環器病研究センター 心臓血管内科)
SY11-2. Challenges of the Osaka Acute Coronary Insufficiency Study for the Publicity and Continuity
砂 真一郎 (大阪大学 循環器内科学)
※こちらの演題は収録しておりません。
SY11-3. Experience and Perspectives from the Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2) Study
坂田 泰彦 (東北大学 循環器内科)
SY11-4. Present Status of Registry for Mechanical Assisted Circulatory Support in Japan (J-MACS)
中谷 武嗣 (J-MACS 業務委員会)
SY11-5. Constructing a Successful Multicenter Registry in Japan: Overcoming the Hurdles with Internet Technology and Skilled CRCs
植田 育子 (慶應義塾大学 循環器内科)
シンポジウム 14(CAD)
座長：
上田 真喜子 (大阪市立大学 病理病態学)
本江 純子 (府中恵仁会病院 心臓血管病センターイメージング研究所)
SY14-1. Working Conditions for Female Cardiologists: Radiation Exposure and Support during Pregnancy ～Current Status in the US and Problems in Japan～
井上 優子 (国立循環器病研究センター 心臓血管内科)
※こちらの演題は収録しておりません。
SY14-2. Radiation Exposure to Female Electrophysiologists Specialized in Catheter Ablation―How to Decrease the Fluoroscopic Time in Atrial Fibrillation Ablation?
吉村 あきの (鹿児島大学 心臓血管・高血圧内科学)
SY14-3. Fluororeduction in Interventional Electrophysiology for Female Doctors
井藤 葉子 (筑波大学 循環器内科)
SY14-4. Why So Few Women in Interventional Cardiac Electrophysiology?
岡﨑 怜子 (日本医科大学多摩永山病院 内科・循環器内科)
SY14-5. Importance to Establish the Working Environment for Equal Career Opportunity for Female Interventional Cardiologists
富岡 智子 (みやぎ県南中核病院 循環器内科)
SY14-6. Current Status and Perspective of Female Interventional Cardiologists in Community Hospital
髙田 睦子 (小松市民病院 内科)
SY14-7. Guideline on Occupational Radiation Exposure to the Pregnant Cardiologist and Technical Personnel
本江 純子 (府中恵仁会病院 心臓血管病センター)
シンポジウム 17(HF)
座長：
松原 広己 (国立病院機構岡山医療センター 臨床研究部)
松原 広己 (国立病院機構岡山医療センター 臨床研究部)
SY17-1. Reactive Post-capillary Pulmonary Hypertension as a New Therapeutic Target for Left Heart Disease
杉村 宏一郎 (東北大学 循環器内科)
SY17-2. Sildenafil and Tadalafil Use in Dual Phosphodiesterase Type 5 Inhibitor Therapy as Salvage Therapy for Refractory Pulmonary Arterial Hypertension
田村 雄一 (慶應義塾大学 循環器内科)
SY17-3. Riociguat for the Treatment of Pulmonary Hypertension
波多野 将 (東京大学 循環器内科)
SY17-4. Nanoparticle-mediated Drug Delivery System of Prostaglandin I2 into Lungs Ameliorates the Development of Monocrotaline-induced Pulmonary Artery Hypertension in Rats
赤木 達 (岡山大学 循環器内科学)
SY17-5. TRPC3/6 as Potentially Novel Therapeutic Targets for the Treatment of Pulmonary Arterial Hypertension
木下 秀之 (京都大学 内分泌代謝内科)
シンポジウム 21(O)
座長：
伊藤 浩 (岡山大学 機能制御学（循環器内科）)
橋本 英樹 (東京大学 公共保健医学専攻)
SY21-1. Automated and Internet-Based Telemedical Management of Heart Failure Using a New Telemonitoring Variable of Respiratory Instability
高川 順也 (射水市民病院 循環器科)
SY21-2. Innovative Remote Interrogation Technology for the Better Management of Patients with Cardiac Implantable Pacing Devices
真中 哲之 (東京女子医科大学 循環器内科学)
SY21-3. Developing an Information Infrastructure for Clinical Research Coordinated with Academic Societies
山本 景一 (国立循環器病研究センター 情報統括部)
SY21-4. Disaster Cardiovascular Prevention IT Network in the Town of Minamisanriku on The Great 2011 East Japan Earthquake
西澤 匡史 (公立志津川病院 内科／自治医科大学 循環器内科学)
SY21-5. Non-invasive Fractional Flow Reserve Computed from CT (FFRCT) as a Novel Method for Diagnosing Coronary Artery Disease: Results from HeartFlowNXT
三好 亨 (岡山大学 先端循環器病治療学)
SY21-6. A New Application of Automatic Illustration System for Better Understanding of Complex Congenital Heart Diseases
黒嵜 健一 (国立循環器病研究センター 小児循環器集中治療室)
Symposium 22(O)
Chairperson：
Masafumi Kitakaze (National Cerebral and Cardiovascular Center, Osaka)
Christine E. Seidman (Brigham & Women’s Hospital and Harvard Medical School, USA)
SY22-KEY. Keynote Lecture： Using Genomic Information to Alter Clinical Outcomes in Patients at Risk for Cardiovascular Disease
Christine E. Seidman (Brigham & Women’s Hospital and Harvard Medical School, USA)
SY22-1. Exploratory Research on Potential Diagnostic as Well as Therapeutic Targets for Heart Failure Using Omics Data Analysis
Masanori Asakura (National Cerebral and Cardiovascular Center, Osaka)
※こちらの演題は収録しておりません。
SY22-2. Research Strategies of Whole Exome Sequencing～Practical Approaches for 110 Patients (32 Families) with Hereditary Cardiomyopathy and Arrhythmia～
Yoshihiro Asano (Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita)
※こちらの演題は収録しておりません。
SY22-3. Genome-wide Association Study (GWAS) for a Cardiac Arrhythmia, Atrial Fibrillation
Tetsushi Furukawa (Department of Bio-informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo)
※こちらの演題は収録しておりません。
SY22-4. Benchtop Next Generation Sequencer has Facillitated the Genetic Analysis for Inherited Arrhythmias
Seiko Ohno (Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu)
ジョイントシンポジウム
AHA-JCS Joint Symposium
Chairperson：
Keiichi Fukuda (Department of Cardiology, Keio University School of Medicine, Tokyo)
Eric N. Olson (University of Texas Southwestern Medical Center, USA)
AHA-JS-1. Reprogramming Fibroblasts toward a Cardiac Cell Fate as a Strategy for Heart Repair
Eric N. Olson (University of Texas Southwestern Medical Center, USA)
AHA-JS-2. Direct Cardiac Reprogramming in vitro
Masaki Ieda (Department of Clinical and Molecular Cardiovascular Research, Department of Cardiology, Keio University School of Medicine, Tokyo)
AHA-JS-3. Cardiac iPSCs for Disease Modeling, Drug Screening, and Cell Therapy
Joseph Wu (Stanford University School of Medicine, USA)
AHA-JS-4. Disease Modeling Using iPS Cells
Tetsushi Furukawa (Department of Bio-informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo)
※こちらの演題は収録しておりません。
ACC-JCS Joint Symposium
Chairperson：
Takashi Akasaka (Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama)
Jagat Narula (Mount Sinai Hospital, USA)
ACC-JS-1. Present Status of Cardiovascular Imagings in the Detection of Vulnerable Plaque
Jagat Narula (Mount Sinai Hospital, USA)
ACC-JS-2. Molecular Imaging for Detecting Vulnerable Plaque
Farouc Jaffer (Massachusetts General Hospital, USA)
ACC-JS-3. High-Intensity Signals in Coronary Plaques on Non-contrast T1-Weighted Magnetic Resonance Imaging as a Novel Determinant of Coronary Events
Teruo Noguchi (Department of Cardiovascular Medicine, National Cerebral & Cardiovascular Center, Suita)
ACC-JS-4. Demonstration of Vulnerable Plaques by Coronary CT Angiography
Sadako Motoyama (Department of Cardiology, Fujita Health University, Toyoake)
ACC-JS-5. Intravascular Imagings in the Assessment of Vulnerable Plaque
Takashi Kubo (Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama)
Meet the ESC
ESC-JCS Guideline Session of Heart Failure
Chairperson：
Yoshihiko Saito (The First Department of Internal Medicine, Nara Medical University, Kashihara)
Panos Vardas (Heraklion University Hospital, Greece)
ESC-GS-1. Current status of Heart Failure in Japan: Epidemiology and Management
Mitsuaki Isobe (Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo)
ESC-GS-2. Acute Coronary Syndrome: Can We Modify the Development of Acute Heart Failure?
Keith Fox (Cardiology of the University of Edinburgh, Great Britain)
ESC-GS-3. Guideline-based Management of “Chronic Heart Failure in Japan”
Tohru Masuyama (Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya)
ESC-GS-4. Guideline-based Management of “Chronic Heart Failure in Europe”
Stefan D. Anker (Charite - Universitatsmedizin Berlin, Germany)
Meet the ESC
TAVI update
Chairperson：
Hirotsugu Mitsuhashi (Cardiovascular Center, St Luke’s International Hospital, Tokyo)
Bernard Chevalier (Massy, France)
ESC-TA-1. Japanese Experience: Role of Surgeon in TAVI
Tetsuya Tohbaru (Division of Cardiology, Sakakibara Heart Institute, Tokyo)
ESC-TA-2. Lessons Learned from＞10-Year Experience of TAVI
Bernard Chevalier (On behalf of ICPS Valve Team, Massy, France)
ESC-TA-3. How to Predict and Manage Procedural Complications of TAVI?
Kentaro Hayashida (Department of Cardiology, Keio University School of Medicine, Tokyo)
ESC-TA-4. The Role of Heart Team―How do We Choose TAVI or SAVR?: A Lesson from SWISS TAVI Registry
Marco Roffi (University Hospital of Geneva, Switzerland)
Meet the ESC ESC-JCS Joint Symposium
Chairperson：
Yukio Ozaki (Department of Cardiology, Fujita Health University Hospital, Toyoake)
Fausto J. Pinto (University Hospital Sta Maria-Dpt Cardiology-Lisbon University, Portugal)
ESC-JS-1. Mechanisms of ACS Assessed by IVUS
Fausto J. Pinto (University Hospital Sta MariaDpt CardiologyLisbon University, Portugal)
ESC-JS-2. Mechanism of Acute Coronary Syndrome Assessed by Optical Coherence Tomography
Takashi Akasaka (Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama)
ESC-JS-3. Influence of Plaque Rupture and Erosion on the Treatment of ACS
Giampaolo Niccoli (Institute of Cardiology Catholic University of the Sacred Heart Rome, Italy)
ESC-JS-4. Current Treatment Strategy in AMI; A Lesson from TROFI Trial
Takashi Muramatsu (Department of Cardiology, Fujita Health University Hospital, Toyoake)
ラウンドテーブルディスカッション 1
座長：
高月 誠司 (慶應義塾大学 循環器内科)
熊谷 浩一郎 (福岡山王病院 ハートリズムセンター)
RT01-1. Ablation Strategy Based on Pulmonary Vein Isolation and Non-pulmonary Vein Trigger Ablation for Non-paroxysmal Atrial Fibrillation
桑原 大志 (横須賀共済病院 循環器センター 内科)
RT01-2. Identification of Persistent Atrial Fibrillation Patients to Whom Pulmonary Vein Isolation Alone was Enough to Maintain Sinus Rhythm
井上 耕一 (桜橋渡辺病院 心臓血管センター)
RT01-3. Coronary Sinus Ablation in Patients with Persistent Atrial Fibrillation
松尾 征一郎 (東京慈恵会医科大学 循環器内科)
RT01-4. The Role of High-Freaquency Stimulation Guided Ganglionated Plexus Ablation for Persistent and Long-lasting Persistent Atrial Fibrillation
山城 荒平 (豊橋ハートセンター 循環器内科)
RT01-5. Intracardiac Ultrasound for Left Atrial Navigation on Catheter Ablation for Atrial Fibrillation
藤生 克仁 (東京大学 循環器内科)
トピック
トピック 3(CAD)
座長：
大木 隆生 (東京慈恵会医科大学 外科学講座)
一色 高明 (帝京大学 内科)
TP03-1. Heart Team Approach to Achieve Better Outcome in Transcatheter Aortic Valve Implantation
林田 健太郎 (慶應義塾大学 循環器内科)
TP03-2. The Importance of the Heart Team in TAVR; From the Surgical Point of View
高梨 秀一郎 (榊原記念病院)
TP03-3. Carotid Artery Stenosis Complicated with Severe Heart Disease
伊苅 裕二 (東海大学 循環器内科学)
TP03-4. Hybrid CABG; Offpomp CABG Continuing Aspirin Early after DES Implantation
樋上 哲哉 (札幌医科大学 心臓血管外科学)
TP03-5. Totally Endovascular Aneurysm Repair for Arch Aneurysms
金岡 祐司 (東京慈恵会医科大学 外科学講座 血管外科)
TP03-6. Hybrid Revascularization for Peripheral Arterial Disease (PAD)
東 信良 (旭川医科大学 循環・呼吸・腫瘍病態外科学)
TP03-7. Future Perspective on Hybrid Therapy Regarding Cardiovascular Diseases
原 英彦 (東邦大学医療センター大橋病院 循環器内科)
トピック 4(O)
座長：
杉浦 清了 (東京大学 新領域創成科学研究科)
中沢 一雄 (国立循環器病研究センター研究所 研究情報基盤管理室)
TP04-1. Clincal Application of Multi-scale Heart Simulator, UT-Heart
杉浦 清了 (東京大学 新領域創成科学研究科)
TP04-2. Technological Development of Heart Simulators for Various Computer Platforms in the Medical and Health-care Fields
中沢 一雄 (国立循環器病研究センター研究所 研究情報基盤管理室)
TP04-3. In Silico Arrhythmology: To Unlock the Future of Arrhythmia Treatment
芦原 貴司 (滋賀医科大学 循環器内科・不整脈センター)
トピック 9(O)
座長：
米村 滋人 (東京大学 法学政治学研究科)
高橋 栄一 (アステラス・アムジェン・バイオファーマ株式会社)
TP09-1. Career Development of Physicians in Pharmaceutical Medicine
今村 恭子 (SBIファーマ株式会社)
TP09-2. Dedication to Health Policy is One of the Career Options for Medical Doctors
迫井 正深 (厚生労働省 老健局老人保健課)
※こちらの演題は収録しておりません。
TP09-3. Physician’s Career Path as a Lawyer
児玉 安司 (新星総合法律事務所／東京大学)
トピック 11(HT)
座長：
木村 剛 (京都大学 循環器内科学)
市原 淳弘 (東京女子医科大学 高血圧・内分泌内科)
TP11-1. Abnormal Sympathoexcitation Causes Hypertension
岸 拓弥 (九州大学 先端心血管治療学)
TP11-2. Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension
池本 智一 (自治医科大学 循環器内科学)
TP11-3. The Effect of Intra-renal Artery Ablation on Cardiovascular Disease and the Problem in the Procedure
奥山 裕司 (大阪大学 先進心血管治療学寄附講座)
TP11-4. Merits and Demerits of Renal Denervation in the Management of Cardiovascular Risk Factors
森本 聡 (東京女子医科大学 第二内科学講座 高血圧・内分泌内科)
コントロバーシー
コントロバーシー 2(A)
座長：
杉 薫 (東邦大学医療センター大橋病院 循環器内科)
高橋 淳 (横須賀共済病院 循環器センター)
C02-1. The Long-term Efficacy and Cardiovascular Prognosis of Antiarrhythmic Drug Therapy in Patients with Paroxysmal Atrial Fibrillation
小松 隆 (岩手医科大学 心血管・腎・内分泌内科)
C02-2. Catheter Ablation is a First-line Therapy for Paroxysmal Atrial Fibrillation
熊谷 浩一郎 (福岡山王病院 ハートリズムセンター)
C02-3. Role of Antiarrhythmic Drugs for Paroxysmal Atrial Fibrillation: Anyone, Anytime, Anywhere
志賀 剛 (東京女子医科大学 循環器内科学)
C02-4. Catheter Ablation for Paroxysmal Atrial Fibrillation Appears to be a Feasible First-line Therapy
松井 由美恵 (大阪府済生会泉尾病院 循環器内科)
コントロバーシー 3(CAD)
座長：
吉野 秀朗 (杏林大学 第二内科)
坂田 隆造 (京都大学 心臓血管外科)
C03-1. Recent Advance which would Decrease a Gap between PCI and CABG Demonstrated in the Syntax Trial
田邉 健吾 (三井記念病院 循環器内科)
C03-2. PCI for an Unprotected LMT Lesion: The Results is Good if We Select Carefully a Lesion by Heart Team
桃原 哲也 (榊原記念病院 循環器内科)
C03-3. CABG and PCI for Unprotected Left Main Trunk Disease: Influence of New-generation Drug Eluting Stent
小宮 達彦 (倉敷中央病院 心臓血管外科)
C03-4. Impact of Evidence-Based Clinical Practice from “Real World” Myocardial Revascularization in Japan: The CREDO Kyoto PCI CABG Registry Cohort 2
丸井 晃 (京都大学 心臓血管外科学)
ミート・ザ・エキスパート
ミート・ザ・エキスパート 5(IM)
座長：
竹中 克 (日本大学板橋病院 循環器内科)
赤阪 隆史 (和歌山県立医科大学 循環器内科)
ME05-1. Role of Echocardiographer in Catheter Intervention for Structural Heart Disease
中谷 敏 (大阪大学 保健学科)
ME05-2. Echocardiographic Assessment of Cardiac Function: Where is the Ultraman?
上松 正朗 (関西労災病院 循環器内科)
ME05-3. Only 3D Echo Knows
竹内 正明 (産業医科大学 第二内科)
ME05-4. The Portable Echo―Who and How Uses It?
林田 晃寛 (川崎医科大学 循環器内科学)
ME05-5. Standardization, Education and Qualification for Reliable Echocardiography
赤石 誠 (北里研究所病院 循環器内科)
ミート・ザ・エキスパート 7(HF)
座長：
中谷 武嗣 (国立循環器病研究センター 移植部)
坂田 隆造 (京都大学 心臓血管外科)
ME07-1. Multidisciplinary Approach for Heart Transplantation: Osaka University Experience
戸田 宏一 (大阪大学 心臓血管外科)
ME07-2. NCVC Experience of Heart Transplantation
中谷 武嗣 (国立循環器病研究センター 移植部)
ME07-3. mTOR Inhibitor can be an Alternative for Standard Immunosuppressive Therapy after Heart Transplantation?
絹川 弘一郎 (東京大学 重症心不全治療開発講座)
ミート・ザ・エキスパート 8(CAD)
座長：
平田 恭信 (東京逓信病院)
森崎 裕子 (国立循環器病研究センター研究所 分子生物学部・臨床遺伝科)
ME08-1. Comprehensive Evaluation and Multidisciplinary Management of Marfan Syndrome Patients
今井 靖 (自治医科大学 循環器内科学)
ME08-2. Genes Causing Hereditary Aortopathy: Genetic Information, Diagnosis, and Disease Management
森崎 隆幸 (国立循環器病研究センター研究所 分子生物学部)
ME08-3. Surgery for Aortic Lesions in Patients with Connective Tissue Disorder
大北 裕 (神戸大学 心臓血管外科)
ME08-4. Analysis of Microfibril Regeneration Mechanisms in Marfan Syndrome by ADAMTSL6β
齋藤 正寛 (東北大学 口腔修復学講座・歯科保存学分野)
閉会式
永井 良三 (自治医科大学／東京大学)
ページのトップへ